ENT‐1‐Targeted Polymersomes to Enhance the Efficacy of Methotrexate in Choriocarcinoma Treatment

Gestational choriocarcinoma (CC) is a rare and highly malignant cancer originating from the trophoblastic layers of the placenta. Currently, methotrexate (MTX) is the first‐line treatment for CC; however, due to the aggressive and metastatic nature of CC, multiple doses are often required, leading t...

Full description

Bibliographic Details

Published in:	Small Science
Main Authors:	Babak Mamnoon, Ana Paula Mesquita Souza, Tetiana Korzun, Maureen K. Baldwin, K. Shitaljit Sharma, Oleh Taratula, Yoon Tae Goo, Prem Singh, Vladislav Grigoriev, Aryan Lakhanpal, Olena R. Taratula
Format:	Article
Language:	English
Published:	Wiley-VCH 2025-07-01
Subjects:	choriocarcinoma ENT‐1‐targeted drug delivery methotrexate nanoplatform polymersome
Online Access:	https://doi.org/10.1002/smsc.202400361